Citations

Citations to this article as recorded by  

• Brigatinib treatment in a patient with advanced NSCLC with XPO1-ALK fusion: a case report
  Yang Zhang, Ke-jie Li, Can Wang, Chang-lin Zou, Meng Su
  Frontiers in Oncology.2025;[Epub]     CrossRef
• Identification of Vesicle‐Mediated Transport‐Related Genes for Predicting Prognosis, Immunotherapy Response, and Drug Screening in Cervical Cancer
  Shuai Lou, Hongqing Lv, Lin Zhang
  Immunity, Inflammation and Disease.2024;[Epub]     CrossRef
• First-line crizotinib therapy is effective for a novel SEC31A-anaplastic lymphoma kinase fusion in a patient with stage IV lung adenocarcinoma: a case report and literature reviews
  Rongrong Wu, Shinan Liu, Guoli Lv, Chaowen Deng, Ruolan Wang, Shenglin Zhang, Dongyi Zhu, Le Wang, Youming Lei, Zhuang Luo
  Anti-Cancer Drugs.2023; 34(2): 294.     CrossRef
• Hallmarks of Anaplastic Lymphoma Kinase Inhibitors with Its Quick Emergence of Drug Resistance
  Yong-Fu Qiu, Lian-Hua Song, Gang-Long Jiang, Zhen Zhang, Xu-Yan Liu, Guan Wang
  Pharmaceutical Fronts.2022; 04(04): e223.     CrossRef
• TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis
  Kyungsoo Jung, Joon-Seok Choi, Beom-Mo Koo, Yu Jin Kim, Ji-Young Song, Minjung Sung, Eun Sol Chang, Ka-Won Noh, Sungbin An, Mi-Sook Lee, Kyoung Song, Hannah Lee, Ryong Nam Kim, Young Kee Shin, Doo-Yi Oh, Yoon-La Choi
  Cancer Research and Treatment.2021; 53(1): 9.     CrossRef
• A case of primary pulmonary atypical carcinoid with EML4-ALK rearrangement
  Na Liu, Jingjing Wang, Xiao Fu, Xiaoqiang Zheng, Huan Gao, Tao Tian, Zhiping Ruan, Yu Yao
  Cancer Biology & Therapy.2020; 21(1): 12.     CrossRef
• Catalog of 5’ Fusion Partners in ALK-positive NSCLC Circa 2020
  Sai-Hong Ignatius Ou, Viola W. Zhu, Misako Nagasaka
  JTO Clinical and Research Reports.2020; 1(1): 100015.     CrossRef

• CircSEC31A Promotes the Malignant Progression of Non-Small Cell Lung Cancer Through Regulating SEC31A Expression via Sponging miR-376a

  
  Fengfeng Cheng, Jing Yu, Xiaoying Zhang, Zongyan Dai, Aiju Fang
  Cancer Management and Research.2020; Volume 12: 11527.     CrossRef
• Discovery Stories of RET Fusions in Lung Cancer: A Mini-Review
  Kengo Takeuchi
  Frontiers in Physiology.2019;[Epub]     CrossRef
• What are the Uncommon Anaplastic Lymphoma Kinase (ALK) Fusions in Non-Small Cell Lung Cancer?
  Hind El Yacoubi, Mohamed Sow, Hassan Errihani
  Integrative Journal of Medical Sciences.2019;[Epub]     CrossRef
• Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic Tumors
  Toby Trahair, Andrew J. Gifford, Ashleigh Fordham, Chelsea Mayoh, Mitali Fadia, Robyn Lukeis, Andrew C. Wood, Santosh Valvi, Roderick D. Walker, James Blackburn, Erin E. Heyer, Tim R. Mercer, Draga Barbaric, Glenn M. Marshall, Karen L. MacKenzie
  JCO Precision Oncology.2019; (3): 1.     CrossRef
• Perspective Insight into Future Potential Fusion Gene Transcript Biomarker Candidates in Breast Cancer
  Ryong Kim, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh
  International Journal of Molecular Sciences.2018; 19(2): 502.     CrossRef
• Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC
  Ka-Won Noh, Insuk Sohn, Ji-Young Song, Hyun-Tae Shin, Yu-Jin Kim, Kyungsoo Jung, Minjung Sung, Mingi Kim, Sungbin An, Joungho Han, Se-Hoon Lee, Mi-Sook Lee, Yoon-La Choi
  Clinical Cancer Research.2018; 24(17): 4162.     CrossRef
• Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment
  Wenbin Li, Jing Zhang, Lei Guo, Shannon Chuai, Ling Shan, Jianming Ying
  Journal of Thoracic Oncology.2017; 12(1): 94.     CrossRef
• Anchored multiplex PCR for targeted next‐generation sequencing reveals recurrent and novel USP6 fusions and upregulation of USP6 expression in aneurysmal bone cyst
  Natalya V. Guseva, Omar Jaber, Munir R. Tanas, Aaron A. Stence, Ramakrishna Sompallae, Jenna Schade, Allison N. Fillman, Benjamin J. Miller, Aaron D. Bossler, Deqin Ma
  Genes, Chromosomes and Cancer.2017; 56(4): 266.     CrossRef
• MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values
  Geun Dong Lee, Seung Eun Lee, Doo-Yi Oh, Dan-bi Yu, Hae Min Jeong, Jooseok Kim, Sungyoul Hong, Hun Soon Jung, Ensel Oh, Ji-Young Song, Mi-Sook Lee, Mingi Kim, Kyungsoo Jung, Jhingook Kim, Young Kee Shin, Yoon-La Choi, Hyeong Ryul Kim
  Journal of Thoracic Oncology.2017; 12(8): 1233.     CrossRef
• Anaplastic Lymphoma Kinase Rearrangements in Non-Small-Cell Lung Cancer: Novel Applications in Diagnostics and Treatment
  Rodney E Shackelford, Junaid M Ansari, Eric X Wei, Jonathan S Alexander, James Cotelingam
  Pharmacogenomics.2017; 18(12): 1179.     CrossRef
• Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
  Ka‐Won Noh, Mi‐Sook Lee, Seung Eun Lee, Ji‐Young Song, Hyun‐Tae Shin, Yu Jin Kim, Doo Yi Oh, Kyungsoo Jung, Minjung Sung, Mingi Kim, Sungbin An, Joungho Han, Young Mog Shim, Jae Ill Zo, Jhingook Kim, Woong‐Yang Park, Se‐Hoon Lee, Yoon‐La Choi
  The Journal of Pathology.2017; 243(3): 307.     CrossRef
• Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects
  Naoko Tsuyama, Kana Sakamoto, Seiji Sakata, Akito Dobashi, Kengo Takeuchi
  Journal of Clinical and Experimental Hematopathology.2017; 57(3): 120.     CrossRef
• Detection of ALK rearrangements in lung cancer patients using a homebrew PCR assay
  Hui Yu, JianHua Chang, Fang Liu, Qifeng Wang, YongMing Lu, ZhuanXu Zhang, Jiabing Shen, Qing Zhai, Xia Meng, Jialei Wang, Xun Ye
  Oncotarget.2017; 8(5): 7722.     CrossRef
• Worse disease-free, tumor-specific, and overall survival in surgically-resected lung adenocarcinoma patients with ALK rearrangement
  Qiongqiong Gao, Pupu Li, Xiangli Jiang, Zhongli Zhan, Qingna Yan, Bo Zhang, Chun Huang
  Oncotarget.2017; 8(49): 86066.     CrossRef
• Technological considerations for genome-guided diagnosis and management of cancer
  Niall J. Lennon, Viktor A. Adalsteinsson, Stacey B. Gabriel
  Genome Medicine.2016;[Epub]     CrossRef
• Identification of a novel partner gene, KIAA1217, fused to RET: Functional characterization and inhibitor sensitivity of two isoforms in lung adenocarcinoma
  Mi-Sook Lee, Ryong Nam Kim, Hoseok I, Doo-Yi Oh, Ji-Young Song, Ka-Won Noh, Yu-Jin Kim, Jung Wook Yang, Maruja E. Lira, Chang Hun Lee, Min Ki Lee, Yeoung Dae Kim, Mao Mao, Joungho Han, Jhingook Kim, Yoon-La Choi
  Oncotarget.2016; 7(24): 36101.     CrossRef